Author: AFHE Team
AFHE Applauds Section 301 Investigation into Germany’s Drug Pricing
Americans for Health Excellence (AFHE) Executive Director Dr. Brad Wenstrup issued the following statement in response to U.S. Trade Representative Jamieson Greer’s initiation of Section 301 investigations against Germany:
“Thank you President Trump and Ambassador Greer for putting Americans and American patients first.
“For too long, wealthy nations like Germany have imposed price controls that force American families to subsidize the world’s drug development. Today’s Section 301 investigation is a direct challenge to that arrangement and a welcome step.
“As a physician, I have seen the costs to patients when the system doesn’t work for them. Foreign exploitation isn’t a trade abstraction — it shows up at the pharmacy counter. Every dollar Germany underpays is a dollar an American patient overpays.”
ABOUT AMERICANS FOR HEALTH EXCELLENCE
Americans for Health Excellence (AFHE) is a 501(c)(4) health policy organization dedicated to building a healthcare system that puts patients first — lowering costs, expanding access, and ensuring every American has the tools and information to make the best healthcare decisions for themselves and their families. AFHE advances market-based solutions while engaging all in the healthcare system on behalf of patient health.
For more information, visit AmericansforHealthExcellence.org.
Dr. Brad Wenstrup: President Trump is Right to Hold Germany Accountable
Following reports that U.S. and German officials are holding secret talks on drug pricing, Americans for Health Excellence (AFHE) Executive Director Dr. Brad Wenstrup issued the following statement in response:
“American patients pay three times more than Germans for new medications, not because our costs are higher, but because Berlin has been offloading those costs onto us for years. The Trump Administration is right to call out Germany’s exploitation of American innovation and demand they pay their share.”
ABOUT AMERICANS FOR HEALTH EXCELLENCE
Americans for Health Excellence (AFHE) is a 501(c)(4) health policy organization dedicated to building a healthcare system that puts patients first — lowering costs, expanding access, and ensuring every American has the tools and information to make the best healthcare decisions for themselves and their families. AFHE advances market-based solutions while engaging all in the healthcare system on behalf of patient health.
For more information, visit AmericansforHealthExcellence.org.
Stephen Moore Op-Ed: Foreign drug price controls are a hidden tax on Americans
Senator Sheehy Op-Ed: Trump was right, Germany was wrong — first on NATO, now on trade
Wenstrup Op-Ed: When insurers deny care, patients pay the price
AFHE Lauds Expansion of TrumpRx Partnership to Include Generic Medicines
Washington, D.C. — Americans for Health Excellence (AFHE) today applauded the Trump Administration’s expansion of the TrumpRx initiative to include generic medicines through a new partnership involving entrepreneur Mark Cuban and Cost Plus Drugs. The expansion builds on the Administration’s effort to lower medication costs through direct-to-consumer purchasing pathways, which bypass the traditional insurance system.
Recent polling from Americans for Health Excellence and McLaughlin & Associates shows voters strongly support market-based reforms that lower costs without relying on government price-setting mandates. Voters consistently support solutions that improve affordability while preserving access, innovation, and patient choice.
Dr. Brad Wenstrup, Executive Director of Americans for Health Excellence, issued the following statement in response:
“American patients shouldn’t have to fight their way through a broken system just to afford the medicines their doctor prescribed. That’s been true in the exam room and it’s true in the halls of Congress—and it’s why work like this matters.
“Expanding TrumpRx to include generic medicines is a real, tangible step for real patients. For the millions of Americans who’ve been squeezed by insurance denials, sky-high copays, and coverage rules designed to confuse rather than help, this is the kind of direct relief they’ve been asking for.
“AFHE applauds the Administration and Cost Plus Drugs for continuing to advance practical, patient-first solutions that help lower costs and expand access.”
AFHE encourages policymakers and health care leaders to continue advancing market-based reforms that ensure savings reach patients directly and help families access the medicines they need without unnecessary barriers.
ABOUT AMERICANS FOR HEALTH EXCELLENCE
Americans for Health Excellence (AFHE) is a 501(c)(4) health policy organization dedicated to building a healthcare system that puts patients first — lowering costs, expanding access, and ensuring every American has the tools and information to make the best healthcare decisions for themselves and their families. AFHE advances market-based solutions while engaging all in the healthcare system on behalf of patient health.
For more information, visit AmericansforHealthExcellence.org.
Americans for Health Excellence Launches Seven Figure Ad Campaign
Today, Americans for Health Excellence (AFHE), launched a seven-figure advertising campaign calling on lawmakers to confront the “foreign freeloading” that forces American patients to subsidize the healthcare systems of wealthy nations.
The launch follows Germany’s announcement of sweeping new mandatory pharmaceutical rebates — a move that deepens the imbalance President Trump has worked to correct through his Most Favored Nation pricing agreements. For decades, wealthy countries like Germany have used government price controls to pay a fraction of what American patients pay for the same medicines, effectively forcing U.S. patients to subsidize their healthcare systems. Germany’s latest mandates are advancing that practice at the precise moment the United States is finally pushing back.
“As a physician and a veteran, I’ve seen firsthand what it costs when Washington fails to stand up for the American patient,” said Dr. Brad Wenstrup, Executive Director of Americans for Health Excellence. “For decades, foreign governments have been exploiting American companies that research, develop, and invent new medicines, driving up costs here while their own citizens pay a fraction of the price. Germany’s latest mandates are just the newest chapter in that same story. President Trump is absolutely right to put America first, and we’re going to ensure lawmakers understand what’s at stake for their constituents.”
The campaign’s opening ad focuses on “foreign freeloading”, highlighting how foreign countries, including Germany, reap the benefits of America’s pharmaceutical inventions while American patients shoulder a disproportionate share of the cost. A March 2026 McLaughlin & Associates survey of 2,000 likely votersfound that 73% of voters support passing legislation that ends the exploitation of America patients shouldering the costs of innovative new treatments and disease cures alone — including 87% of Republicans, 63% of Democrats, and 66% of Independents. A separate question found 79% support a policy that would require foreign countries to pay their fair share for American medicines, enabling American companies to invest those returns in U.S. healthcare infrastructure like hospitals and telehealth.
AFHE’s broader campaign will build on the momentum of President Trump’s TrumpRx initiative and his Most Favored Nation voluntary agreements — supported by 73% of voters — and press Congress to deliver the next wave of patient wins: holding insurers and hospitals accountable for their share of healthcare costs, expanding direct savings at the pharmacy counter, and passing legislation that ensures foreign nations contribute their fair share permanently.
ABOUT AMERICANS FOR HEALTH EXCELLENCE
Americans for Health Excellence (AFHE) is a 501(c)(4) health policy organization dedicated to building a healthcare system that puts patients first — lowering costs, expanding access, and ensuring every American has the tools and information to make the best healthcare decisions for themselves and their families. AFHE advances market-based solutions while engaging all in the healthcare system on behalf of patient health.
For more information, visit AmericansforHealthExcellence.org.
AFHE Hails $529 Billion in Projected Savings from President Trump’s MFN Drug Pricing Agreements
Americans for Health Excellence (AFHE) issued the following statement in response to the Council of Economic Advisers report projecting $529 billion in savings to the American economy over the next decade—derived from the President’s voluntary Most Favored Nation pricing agreements with 17 leading pharmaceutical manufacturers.
“This is a tremendous win for patients and families, and a testament to the President’s commitment to tackling the high cost of prescription drugs head on,” said Dr. Brad Wenstrup, Executive Director of Americans for Health Excellence. “The President’s voluntary MFN agreements are already delivering historic savings for American patients—and as the CEA’s own analysis shows, this framework was built hand-in-glove with U.S. trade policy to end the foreign exploitation that has forced American patients to shoulder an unfair share of the world’s pharmaceutical costs – for decades! These agreements are a powerful start. This trade enforcement track is what is delivering positive results for us.”
AFHE will continue pressing to double down on ending the unfairness to America that comes with what many call “foreign freeloading.” We stand with getting other countries to pay their fair share—while advancing commonsense solutions that lower out-of-pocket costs for patients at the pharmacy counter. An example of common sense can be seen in Rep. (Dr.) Greg Murphy’s “Every Dollar Counts Act,” which ensures that every dollar a patient spends on their medicine counts toward their deductible. AFHE will also work to hold insurers and PBMs accountable for the confusion and costs they too often impose on patients while protecting the sanctity of the patient–doctor relationship as the center of the American healthcare experience.
AFHE looks forward to working with the Trump administration, Congress, and other like-minded partners to make healthcare more affordable, transparent, and excellent for every American.
ABOUT AMERICANS FOR HEALTH EXCELLENCE
Americans for Health Excellence (AFHE) is a 501(c)(4) health policy organization dedicated to building a healthcare system that puts patients first — lowering costs, expanding access, and ensuring every American has the tools and information to make the best healthcare decisions for themselves and their families. AFHE advances market-based solutions while engaging all in the healthcare system on behalf of patient health.
For more information, visit AmericansforHealthExcellence.org.
